Related references
Note: Only part of the references are listed.Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas
Juliette Desfrancois et al.
PLOS ONE (2010)
A Novel Role of Interleukin-13 Receptor α2 in Pancreatic Cancer Invasion and Metastasis
Toshio Fujisawa et al.
CANCER RESEARCH (2009)
Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions
Juliette Desfrancois et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Intestinal double-positive CD4+CD8+ T cells of neonatal rhesus macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection
Xiaolei Wang et al.
BLOOD (2008)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis
Yann Parel et al.
ARTHRITIS AND RHEUMATISM (2007)
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
Caroline Aspord et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?
S. Olver et al.
TISSUE ANTIGENS (2007)
A double-positive CD4+CD8+T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma
Aliyah Rahemtullah et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis
P Sinha et al.
CANCER RESEARCH (2005)
Vγ9Vδ2 T cell response to colon carcinoma cells
M Corvaisier et al.
JOURNAL OF IMMUNOLOGY (2005)
αvβ3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen
E Godefroy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cancer gene therapy utilizing interleukin-13 receptor α2 chain
K Kawakami
CURRENT GENE THERAPY (2005)
CD4+CD8+double positive (DP) T cells in health and disease
Y Parel et al.
AUTOIMMUNITY REVIEWS (2004)
Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes
H Benlalam et al.
JOURNAL OF IMMUNOLOGY (2003)
An important regulatory role for CD4+CD8αα T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease
G Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Immunology and immunotherapy of colorectal cancer
P Dalerba et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: An eotaxin and STAT6-dependent process
J Mattes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens
M Linnebacher et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
